Topics
Low-grade gliomas | Treatment | Targeted therapy | Trametinib
Home > Publications > Topics > Low-grade gliomas > Treatment > Targeted terapy > Trametinib
Dar MS, Shahid N, Waqas A, Baig YA,
Khan AW.
Dabrafenib
plus Trametinib: A breakthrough in pediatric low-grade glioma
therapy.
Health
Sci Rep. 2024 Jan
25;7(1):e1841. doi:
10.1002/hsr2.1841. PMID:
38274133. Interventional
study. ˍ
Papusha
L, Zaytseva M, Panferova A, Salnikova E, Samarin A, Vilesova I,
Voronin K, Protsvetkina A, Podlipaeva S, Zakharov I, Usman N,
Hwang E, Karachunskiy A, Packer RJ, Novichkova G, Druy A.
Midline
Low-Grade Gliomas of Early Childhood: Focus on Targeted Therapies.
JCO
Precis Oncol.
2024 Jul 8;8:e2300590. doi:
10.1200/PO.23.00590. PMID:
38976815. Observational study˰ ˍ
Sheikh SR, Klesse LJ, Mangum R, Bui A, Siegel BI, Abdelbaki MS,
Patel NJ.
The
role of MEK inhibition in pediatric
low-grade gliomas.
Front
Oncol. 2024 Dec 20;14:1503894. doi:
10.3389/fonc.2024.1503894. PMID:
39759151. Review. ˍ